BACKGROUND: Retrocyclins are cyclic antimicrobial peptides that have been shown to be both broadly active and safe in animal models. RC-101, a synthetic retrocyclin, targets important human pathogens and is a candidate vaginal microbicide. Its activity against microbes associated with bacterial vaginosis is unknown. METHODS: We investigated the effect of RC-101 on toxin activity, bacterial growth and biofilm formation of Gardnerella vaginalis in vitro. RESULTS: RC-101 potently inhibits the cytolytic activity of vaginolysin, the Gardnerella vaginalis toxin, on both erythrocytes and nucleated cells. RC-101 lacks inhibitory activity against planktonic G. vaginalis but markedly decreases biofilm formation. CONCLUSIONS: These dual properties, toxin inhibition and biofilm retardation, justify further exploration of RC-101 as a candidate agent for bacterial vaginosis prevention.
BACKGROUND: Retrocyclins are cyclic antimicrobial peptides that have been shown to be both broadly active and safe in animal models. RC-101, a synthetic retrocyclin, targets important human pathogens and is a candidate vaginal microbicide. Its activity against microbes associated with bacterial vaginosis is unknown. METHODS: We investigated the effect of RC-101 on toxin activity, bacterial growth and biofilm formation of Gardnerella vaginalis in vitro. RESULTS:RC-101 potently inhibits the cytolytic activity of vaginolysin, the Gardnerella vaginalis toxin, on both erythrocytes and nucleated cells. RC-101 lacks inhibitory activity against planktonic G. vaginalis but markedly decreases biofilm formation. CONCLUSIONS: These dual properties, toxin inhibition and biofilm retardation, justify further exploration of RC-101 as a candidate agent for bacterial vaginosis prevention.
Authors: Alexander Swidsinski; Werner Mendling; Vera Loening-Baucke; Sonja Swidsinski; Yvonne Dörffel; Jürgen Scholze; Herbert Lochs; Hans Verstraelen Journal: Am J Obstet Gynecol Date: 2007-11-19 Impact factor: 8.661
Authors: Alexander Swidsinski; Yvonne Doerffel; Vera Loening-Baucke; Sonja Swidsinski; Hans Verstraelen; Mario Vaneechoutte; Vesna Lemm; Johannes Schilling; Werner Mendling Journal: Gynecol Obstet Invest Date: 2010-10-16 Impact factor: 2.031
Authors: Ryan Rampersaud; Paul J Planet; Tara M Randis; Ritwij Kulkarni; Jorge L Aguilar; Robert I Lehrer; Adam J Ratner Journal: J Bacteriol Date: 2010-12-17 Impact factor: 3.490
Authors: Alexander M Cole; Teresa Hong; Lee Ming Boo; Tung Nguyen; Chengquan Zhao; Greg Bristol; Jerome A Zack; Alan J Waring; Otto O Yang; Robert I Lehrer Journal: Proc Natl Acad Sci U S A Date: 2002-02-19 Impact factor: 11.205
Authors: Jennifer L Patterson; Philippe H Girerd; Nicole W Karjane; Kimberly K Jefferson Journal: Am J Obstet Gynecol Date: 2007-08 Impact factor: 8.661
Authors: Robert I Lehrer; Grace Jung; Piotr Ruchala; Wei Wang; Ewa D Micewicz; Alan J Waring; Eugene J Gillespie; Kenneth A Bradley; Adam J Ratner; Richard F Rest; Wuyuan Lu Journal: Infect Immun Date: 2009-07-06 Impact factor: 3.441
Authors: Alexandra B Sassi; Katherine E Bunge; Brian L Hood; Thomas P Conrads; Alexander M Cole; Phalguni Gupta; Lisa C Rohan Journal: AIDS Res Ther Date: 2011-07-29 Impact factor: 2.250
Authors: Nitya Venkataraman; Amy L Cole; Piotr Ruchala; Alan J Waring; Robert I Lehrer; Olga Stuchlik; Jan Pohl; Alexander M Cole Journal: PLoS Biol Date: 2009-04-28 Impact factor: 8.029
Authors: Daniela Machado; Joana Castro; Ana Palmeira-de-Oliveira; José Martinez-de-Oliveira; Nuno Cerca Journal: Front Microbiol Date: 2016-01-20 Impact factor: 5.640